Tiziana Life Sciences has signed a Memorandum of Understanding with Saudi Arabia's King Abdullah International Medical Research Center and the Foundation for Neurologic Diseases to study a combination therapy for multiple sclerosis (MS). The trial will focus on relapsing-remitting MS patients who respond poorly to anti-CD20 therapy alone, using Tiziana's intranasal foralumab, which has shown promise in reducing neuroinflammation. This collaboration expands Tiziana's MS research beyond its ongoing secondary progressive MS program, with Phase 2 trial results expected in October. The announcement boosted Tiziana's shares by over 18%.
Tiziana Life Sciences' partnership on MS therapy trial is presented alongside Pluang's health sector snapshot as of Sep 17, 2026 22:21 WIB. Among 91 priced health-sector US stocks, 65 rose and 25 fell. Notably, BioNano Genomics Inc (BNGO) gained 10.60% at USD 1.67 with a typical hold time of 49 days, contrasting with AbCellera Biologics Inc (ABCL) which rose 10.54% to USD 12.90 but saw 99% sell order activity. Novavax Inc (NVAX) increased 8.82% to USD 10.18, with a full buy order activity and a longer hold time of 59 days.
The fourth Digital Assets & Tokenization Summit held in Singapore brought together global financial leaders, institutional investors, and tech innovators to discuss how AI, tokenization, and digital assets are transforming capital markets. Key discus...
A London-based novelist, using the pen name A. Nobody, has independently published a thriller titled "A Nobody: London Doesn't Believe in Superheroes." The story follows a masked hero who stops violent crimes in London anonymously, reflecting the aut...
Coastal Community Bank has committed $5 million to the Solomon Hess SBA Loan Fund to support small businesses in Snohomish and King Counties. This investment helps expand access to capital for businesses that may not qualify for traditional loans, fo...
Equity Bancshares reported Q3 2026 GAAP EPS of $1.29, matching analyst estimates, while its core EPS of $1.40 exceeded expectations by $0.10. The bank continues its strategy of growth through acquisitions, announcing a deal with Lincoln Bancorp, thou...
Brian Vieten, a senior analyst at Siebert Financial, forecasts Bitcoin prices exceeding $175,000 in the coming quarters, driven by increased institutional ownership and expanded financing options. He highlights the role of ETFs, AI-powered mining, an...
